POLG (DNA polymerase subunit gamma-1) variants and mutations
POLG (also known as DNA polymerase subunit gamma-1) is a human protein-coding gene encoding a DNA polymerase subunit gamma-1 protein. It replicates and repairs mitochondrial DNA and is therefore essential for maintaining mitochondrial genome copy number and integrity. Pathogenic variants cause a broad spectrum including Alpers syndrome, progressive external ophthalmoplegia, epilepsy, ataxia, neuropathy, and liver disease. This analysis covers 2,426 POLG variants and mutations. Of these, 71% have computational variant effect predictions. Disease context includes mitochondrial DNA depletion syndrome 4a, sensory ataxic neuropathy, dysarthria, and ophthalmoparesis, and progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal. Example POLG variants include S2N, R3C, and R3P.
Variant analysis overview
- Gene: POLG
- Protein: DNA polymerase subunit gamma-1
- UniProt accession: P54098
- Organism: Homo sapiens
- Variants analyzed: 2426
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 2,295 unspecified-consequence records; 16 frameshift variants; 50 synonymous variants; 48 missense variants; 1 in-frame insertions; 3 splice-region variants; 2 stop-gained variants; 5 in-frame deletions; 6 substitution
- Prediction scores: 1,723 variants have prediction scores (71% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: mitochondrial DNA depletion syndrome 4a, sensory ataxic neuropathy, dysarthria, and ophthalmoparesis, progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal, mitochondrial neurogastrointestinal encephalomyopathy, Sensory ataxic neuropathy - dysarthria - ophthalmoparesis, Alpers syndrome, spinocerebellar ataxia with epilepsy, mitochondrial DNA depletion syndrome, autosomal dominant progressive external ophthalmoplegia, autosomal recessive progressive external ophthalmoplegia, mitochondrial disease, Fanconi anemia.
Protein structure and variant hotspots
- Protein features: 25 binding sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable POLG variants
Examples include S2N, R3C, R3P, L4Q, L5F, W6*, W6S, R7G. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- S2N (p.Ser2Asn), gnomAD rs1358669217, REVEL 0.27, CADD 18.10
- R3C (p.Arg3Cys), Ensembl rs1484763580, REVEL 0.57, CADD 32.00, Uncertain significance, Progressive sclerosing poliodystrophy
- R3P (p.Arg3Pro), rs121918045, ClinGen CA256885, ClinVar RCV000014445, UniProt VAR 012153, REVEL 0.65, CADD 26.80, Pathogenic, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal
- L4Q (p.Leu4Gln), cosmic curated COSV51521
- L5F (p.Leu5Phe), rs761648850, ClinGen CA7725215, ClinVar RCV000625941, ClinVar RCV005091823, REVEL 0.17, CADD 23.40, Uncertain significance, Mitochondrial DNA depletion syndrome 4b; Progressive sclerosing poliodystrophy
- W6* (p.Trp6Ter), rs2509278357, ClinGen CA393775418, ClinVar RCV003131252, CADD 37.00, Likely pathogenic
- W6S (p.Trp6Ser), rs1057524249, ClinGen CA10602200, ClinVar RCV000443728, ClinVar RCV000758292, REVEL 0.48, CADD 24.70, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- R7G (p.Arg7Gly), TOPMed rs1429742906, REVEL 0.25, CADD 24.40
- R7S (p.Arg7Ser), TOPMed rs1057523280, REVEL 0.20, CADD 23.20, Likely benign
- R7W (p.Arg7Trp), rs1429742906, ClinGen CA393775402, ClinVar RCV002741823, REVEL 0.37, CADD 25.60, Uncertain significance, Progressive sclerosing poliodystrophy
- K8N (p.Lys8Asn), rs886044323, ClinGen CA10602224, ClinVar RCV000260803, ClinVar RCV003765675, REVEL 0.13, CADD 22.60, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- K8R (p.Lys8Arg), TOPMed rs1173844824
- V9M (p.Val9Met), rs2509278336, ClinGen CA393775353, ClinVar RCV002304737, REVEL 0.23, CADD 22.50, Uncertain significance, Progressive sclerosing poliodystrophy
- A10D (p.Ala10Asp), 1000Genomes rs774459114, ExAC rs774459114, TOPMed rs774459114, gnomAD rs774459114, REVEL 0.26, CADD 22.80, Likely benign
- A10V (p.Ala10Val), rs774459114, ClinGen CA7725214, ClinVar RCV000537593, ClinVar RCV006438206, REVEL 0.27, CADD 21.70, Likely benign, Progressive sclerosing poliodystrophy
- G11A (p.Gly11Ala), rs765472726, ClinGen CA393775290, ClinVar RCV003628035, ExAC rs765472726, REVEL 0.16, CADD 12.50, Uncertain significance, Progressive sclerosing poliodystrophy
- G11D (p.Gly11Asp), rs765472726, ClinGen CA302812, cosmic curated COSV51524, ClinVar RCV000633544, REVEL 0.45, CADD 15.50, Conflicting interpretations, POLG-related disorder; Progressive sclerosing poliodystrophy; Sensory ataxic neu
- G11S (p.Gly11Ser), rs764055826, ClinGen CA7725213, ClinVar RCV000758320, ExAC rs764055826, REVEL 0.19, CADD 9.97, Likely benign, Progressive sclerosing poliodystrophy
- G11V (p.Gly11Val), rs765472726, ClinGen CA393775294, ClinVar RCV000532508, ExAC rs765472726, REVEL 0.20, CADD 15.30, Uncertain significance, Progressive sclerosing poliodystrophy
- A12G (p.Ala12Gly), TOPMed rs1438282314, gnomAD rs1438282314, Uncertain significance
- A12P (p.Ala12Pro), TOPMed rs1407299239
- A12T (p.Ala12Thr), cosmic curated COSV51522, REVEL 0.11, CADD 21.70
- A12V (p.Ala12Val), rs1438282314, ClinGen CA393775261, ClinVar RCV003194759, ClinVar RCV003779701, REVEL 0.11, CADD 17.30, Uncertain significance, Progressive sclerosing poliodystrophy; Inborn genetic diseases
- T13A (p.Thr13Ala), rs999643917, ClinGen CA274566823, ClinVar RCV001048223, ClinVar RCV003223693, REVEL 0.18, CADD 11.80, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- T13S (p.Thr13Ser), rs1199924512, ClinGen CA10602286, ClinVar RCV000712808, ClinVar RCV001052244, REVEL 0.11, CADD 8.26, Uncertain significance, Inborn genetic diseases; not provided; Hereditary spastic paraplegia
- V14I (p.Val14Ile), gnomAD rs1256681634, REVEL 0.09, CADD 11.20
- G15R (p.Gly15Arg), TOPMed rs1341432047, gnomAD rs1341432047, REVEL 0.27, CADD 16.70
- G15V (p.Gly15Val), TOPMed rs1351464901
- G15W (p.Gly15Trp), TOPMed rs1341432047, gnomAD rs1341432047, REVEL 0.31, CADD 22.50
- P16L (p.Pro16Leu), gnomAD rs1315209124, REVEL 0.24, CADD 24.30
- P16S (p.Pro16Ser), rs1223347965, ClinGen CA393775183, ClinVar RCV003515564, REVEL 0.10, CADD 20.10, Uncertain significance, Progressive sclerosing poliodystrophy
- P16T (p.Pro16Thr), Ensembl rs1223347965, REVEL 0.10, CADD 22.70
- P18L (p.Pro18Leu), rs1394515933, ClinGen CA393775096, ClinVar RCV001991076, gnomAD rs1394515933, REVEL 0.16, CADD 7.30, Uncertain significance, Progressive sclerosing poliodystrophy
- P18Q (p.Pro18Gln), rs1394515933, ClinGen CA393775098, ClinVar RCV001901127, gnomAD rs1394515933, Uncertain significance, Progressive sclerosing poliodystrophy
- P18S (p.Pro18Ser), rs3087373, ClinGen CA341889, ClinVar RCV001851970, UniProt VAR 014904, REVEL 0.11, CADD 17.60, Uncertain significance, Progressive sclerosing poliodystrophy
- V19A (p.Val19Ala), rs770885465, ClinGen CA7725211, ClinVar RCV001587805, ClinVar RCV002592482, REVEL 0.09, CADD 5.18, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- P20S (p.Pro20Ser), rs1596362883, ClinGen CA393775048, ClinVar RCV001373260, Ensembl rs1596362883, REVEL 0.18, CADD 16.80, Uncertain significance, Progressive sclerosing poliodystrophy
- A21G (p.Ala21Gly), TOPMed rs796052893, gnomAD rs796052893, REVEL 0.17, CADD 16.90, Uncertain significance
- A21P (p.Ala21Pro), gnomAD rs1398079290, REVEL 0.32, CADD 22.60, Uncertain significance, not provided
- A21S (p.Ala21Ser), rs1398079290, ClinGen CA393775030, ClinVar RCV003081562, REVEL 0.25, CADD 17.20, Uncertain significance, Progressive sclerosing poliodystrophy
- A21T (p.Ala21Thr), gnomAD rs1398079290, Uncertain significance
- A21V (p.Ala21Val), rs796052893, ClinGen CA316734, ClinVar RCV002353954, ClinVar RCV003098190, REVEL 0.10, CADD 16.50, Uncertain significance, Progressive sclerosing poliodystrophy; Inborn genetic diseases
- P22L (p.Pro22Leu), cosmic curated COSV51524, TOPMed rs1162380960, gnomAD rs1162380960, REVEL 0.16, CADD 14.20
- P22S (p.Pro22Ser), rs568058975, ClinGen CA274566771, ClinVar RCV001214773, 1000Genomes rs568058975, REVEL 0.10, CADD 12.10, Uncertain significance, Progressive sclerosing poliodystrophy
- P22T (p.Pro22Thr), rs568058975, ClinGen CA393775018, ClinVar RCV003627980, REVEL 0.12, CADD 8.39, Uncertain significance, Progressive sclerosing poliodystrophy
- G23A (p.Gly23Ala), gnomAD rs1250766829
- G23R (p.Gly23Arg), rs1422899388, ClinGen CA393774995, cosmic curated COSV51525, ClinVar RCV002048453, REVEL 0.14, CADD 14.70, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- R24C (p.Arg24Cys), rs1196273210, ClinGen CA10602296, ClinVar RCV000758484, TOPMed rs1196273210, Uncertain significance, Progressive sclerosing poliodystrophy
- R24H (p.Arg24His), cosmic curated COSV10803, ExAC rs773375256, TOPMed rs773375256, gnomAD rs773375256, REVEL 0.34, CADD 24.10, Uncertain significance
- R24L (p.Arg24Leu), rs773375256, ClinGen CA7725209, ClinVar RCV003854413, ExAC rs773375256, REVEL 0.29, CADD 22.70, Uncertain significance, Progressive sclerosing poliodystrophy
- R24S (p.Arg24Ser), rs1196273210, ClinGen CA393774982, ClinVar RCV001219852, TOPMed rs1196273210, REVEL 0.40, CADD 23.50, Uncertain significance, Progressive sclerosing poliodystrophy
- W25* (p.Trp25Ter), rs1021719232, ClinGen CA274566757, ClinVar RCV000855758, TOPMed rs1021719232, CADD 36.00, Pathogenic
- W25L (p.Trp25Leu), rs1157410900, ClinGen CA393774961, ClinVar RCV002296789, REVEL 0.28, CADD 23.30, Uncertain significance, Progressive sclerosing poliodystrophy
- W25R (p.Trp25Arg), Ensembl rs2055630808, REVEL 0.41, CADD 19.50, Uncertain significance, Progressive sclerosing poliodystrophy
- W25S (p.Trp25Ser), TOPMed rs1157410900, gnomAD rs1157410900, REVEL 0.37, CADD 22.60
- V26I (p.Val26Ile), rs2509278030, ClinGen CA393774953, ClinVar RCV002295072, REVEL 0.22, CADD 15.40, Uncertain significance, Progressive sclerosing poliodystrophy
- S28C (p.Ser28Cys), rs1567194544, ClinGen CA10602299, ClinVar RCV000758487, Ensembl rs1567194544, Likely benign, Progressive sclerosing poliodystrophy
- S28N (p.Ser28Asn), gnomAD rs1198588992, REVEL 0.22, CADD 21.00
- S28R (p.Ser28Arg), Ensembl rs1567194544, REVEL 0.18, CADD 23.00, Likely benign
- S29C (p.Ser29Cys), rs796052895, ClinGen CA316744, ClinVar RCV000712811, ClinVar RCV002517883, REVEL 0.30, CADD 25.20, Uncertain significance, Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal
- S29P (p.Ser29Pro), rs2509277986, ClinGen CA393774901, ClinVar RCV003515935, ClinVar RCV004765915, REVEL 0.24, CADD 23.70, Uncertain significance, Progressive sclerosing poliodystrophy; not provided
- V30I (p.Val30Ile), rs1321405180, ClinGen CA393774878, ClinVar RCV000995422, ClinVar RCV002290510, REVEL 0.14, CADD 18.60, Uncertain significance, not specified; not provided; Progressive external ophthalmoplegia with mitochond
- P31S (p.Pro31Ser), rs1310226901, ClinGen CA393774849, ClinVar RCV002211313, gnomAD rs1310226901, REVEL 0.14, CADD 1.22, Uncertain significance, not provided
- A32T (p.Ala32Thr), rs748448370, ClinGen CA7725208, cosmic curated COSV10876, ClinVar RCV003859699, REVEL 0.19, CADD 12.50, Uncertain significance, Progressive sclerosing poliodystrophy
- A32V (p.Ala32Val), NCI-TCGA Cosmic COSV5152, cosmic curated COSV51520, REVEL 0.26, CADD 0.01, Uncertain significance, not provided
- S33C (p.Ser33Cys), rs796052896, ClinGen CA316752, ClinVar RCV000188611, TOPMed rs796052896, REVEL 0.22, CADD 21.10, Uncertain significance, not provided
- D34G (p.Asp34Gly), rs779409525, ClinGen CA16620029, ClinVar RCV000480314, ExAC rs779409525, Uncertain significance, not provided
- D34N (p.Asp34Asn), gnomAD rs1330678512, REVEL 0.25, CADD 19.60
- D34V (p.Asp34Val), rs779409525, ClinGen CA7725207, ClinVar RCV000518685, ExAC rs779409525, REVEL 0.13, CADD 7.57, Uncertain significance, not specified
- D34Y (p.Asp34Tyr), gnomAD rs1330678512
- P35H (p.Pro35His), ExAC rs769214289, TOPMed rs769214289, gnomAD rs769214289, REVEL 0.16, CADD 22.90, Uncertain significance, Progressive sclerosing poliodystrophy
- P35L (p.Pro35Leu), rs769214289, ClinGen CA7725206, ClinVar RCV001992950, ExAC rs769214289, REVEL 0.17, CADD 23.10, Uncertain significance, Progressive sclerosing poliodystrophy
- P35S (p.Pro35Ser), cosmic curated COSV51522, REVEL 0.17, CADD 16.20
- S36N (p.Ser36Asn), NCI-TCGA TCGA novel, REVEL 0.30, CADD 19.40, Variant assessed as somatic; moderate impact.
- S36R (p.Ser36Arg), Ensembl rs1596362804, REVEL 0.21, CADD 22.70, Uncertain significance, Progressive sclerosing poliodystrophy
- S36T (p.Ser36Thr), rs2055629992, ClinGen CA393774751, ClinVar RCV002636359, ClinVar RCV003222438, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- D37E (p.Asp37Glu), gnomAD rs1380599126, REVEL 0.29, CADD 14.00, Likely benign
- D37N (p.Asp37Asn), rs2055629922, ClinGen CA393774736, ClinVar RCV001116625, ClinVar RCV005712364, Uncertain significance, Inborn genetic diseases; POLG-related disorder
- G38E (p.Gly38Glu), rs1403540142, ClinGen CA393774695, ClinVar RCV001986546, TOPMed rs1403540142, REVEL 0.19, CADD 22.50, Uncertain significance, Progressive sclerosing poliodystrophy
- G38R (p.Gly38Arg), rs866945104, ClinGen CA274566710, cosmic curated COSV99174, ClinVar RCV001757040, REVEL 0.18, CADD 23.10, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- G38W (p.Gly38Trp), TOPMed rs866945104, gnomAD rs866945104, REVEL 0.18, CADD 25.50, Uncertain significance, Progressive sclerosing poliodystrophy
- Q39* (p.Gln39Ter), TOPMed rs1331116774, CADD 37.00
- Q39R (p.Gln39Arg), rs749750052, ClinGen CA316602, ClinVar RCV000188523, ClinVar RCV000723678, REVEL 0.19, CADD 0.08, Conflicting interpretations, not specified; not provided; Progressive sclerosing poliodystrophy
- R40L (p.Arg40Leu), rs200946722, ClinGen CA393774633, ClinVar RCV001509502, ClinVar RCV001865967, Uncertain significance, Progressive sclerosing poliodystrophy; not provided
- R40Q (p.Arg40Gln), cosmic curated COSV10726, Ensembl rs200946722, REVEL 0.17, CADD 4.66, Uncertain significance
- R40W (p.Arg40Trp), rs1452716613, TOPMed rs1452716613, gnomAD rs1452716613, REVEL 0.27, CADD 20.50, Uncertain significance, Progressive sclerosing poliodystrophy
- R41Q (p.Arg41Gln), rs556175571, ClinGen CA7725203, cosmic curated COSV51522, ClinVar RCV000676335, REVEL 0.20, CADD 0.30, Uncertain significance, Progressive sclerosing poliodystrophy
- R41W (p.Arg41Trp), cosmic curated COSV51523, REVEL 0.21, CADD 18.30
- R42L (p.Arg42Leu), ExAC rs74382477, gnomAD rs74382477, Likely benign
- R42Q (p.Arg42Gln), rs74382477, ClinGen CA316606, NCI-TCGA Cosmic COSV5151, cosmic curated COSV51519, REVEL 0.32, CADD 0.44, Conflicting interpretations, POLG-related disorder; not provided; Hereditary spastic paraplegia
- R42A (p.Arg42Ala), rs2509277695, ClinGen CA2739269696, ClinVar RCV003628130, Pathogenic
- R42G (p.Arg42Gly), ExAC rs755553960, TOPMed rs755553960, gnomAD rs755553960, REVEL 0.24, CADD 10.80, Uncertain significance, not provided
- R42W (p.Arg42Trp), ExAC rs755553960, TOPMed rs755553960, gnomAD rs755553960, REVEL 0.24, CADD 18.70, Uncertain significance, Progressive sclerosing poliodystrophy
- Q43L (p.Gln43Leu), rs28567406, ClinGen CA393774547, ClinVar RCV000733617, 1000Genomes rs28567406, REVEL 0.37, CADD 0.00, Uncertain significance, not provided
- Q43R (p.Gln43Arg), rs28567406, ClinGen CA288980, cosmic curated COSV51520, ClinVar RCV000118010, REVEL 0.30, CADD 0.00, Benign, POLG-related disorder; Inborn genetic diseases; not specified
- Q44* (p.Gln44Ter), rs2509277475, ClinVar RCV004574589, ClinVar RCV005006440, CADD 34.00, Likely pathogenic
- Q44H (p.Gln44His), rs1596362738, ClinGen CA393774490, ClinVar RCV001912423, Ensembl rs1596362738, REVEL 0.21, CADD 9.95, Uncertain significance, Progressive sclerosing poliodystrophy
- Q44R (p.Gln44Arg), rs757120802, ClinGen CA241477, ClinVar RCV000551143, ClinVar RCV000724683, REVEL 0.19, CADD 1.04, Conflicting interpretations, Inborn genetic diseases; Progressive external ophthalmoplegia with mitochondrial
- Q45H (p.Gln45His), rs2055628541, ClinGen CA393774431, ClinVar RCV003628150, Uncertain significance, Progressive sclerosing poliodystrophy
- Q45L (p.Gln45Leu), 1000Genomes rs201016638, TOPMed rs201016638, gnomAD rs201016638, Uncertain significance, not provided
- Q45R (p.Gln45Arg), rs201016638, ClinGen CA302810, cosmic curated COSV51521, ClinVar RCV000175733, REVEL 0.25, CADD 6.88, Benign/Likely benign, Inborn genetic diseases; not specified; Progressive sclerosing poliodystrophy
- Q46* (p.Gln46Ter), rs2055628382, ClinGen CA393774410, ClinVar RCV003515570, Ensembl rs2055628382, CADD 33.00, Pathogenic
- Q46H (p.Gln46His), gnomAD rs1234024731, REVEL 0.27, CADD 7.58
- Q46R (p.Gln46Arg), rs1555454339, ClinGen CA10602190, ClinVar RCV000596845, ClinVar RCV000758405, REVEL 0.31, CADD 6.72, Uncertain significance, Progressive sclerosing poliodystrophy
- Q47* (p.Gln47Ter), gnomAD rs1332797348
- Q47E (p.Gln47Glu), rs1332797348, ClinGen CA393774374, ClinVar RCV003626997, Uncertain significance, Progressive sclerosing poliodystrophy
- Q47R (p.Gln47Arg), Ensembl rs2055627970
- Q48E (p.Gln48Glu), rs1299097778, ClinGen CA393774341, ClinVar RCV003626430, gnomAD rs1299097778, REVEL 0.27, CADD 0.24, Uncertain significance, Progressive sclerosing poliodystrophy
- Q48H (p.Gln48His), ExAC rs763968001, gnomAD rs763968001, REVEL 0.23, CADD 0.66
- Q48R (p.Gln48Arg), rs2141816053, ClinGen CA393774324, ClinVar RCV001984925, Ensembl rs2141816053, REVEL 0.28, CADD 4.32, Uncertain significance, Progressive sclerosing poliodystrophy
- Q49* (p.Gln49Ter), rs200132079, ClinGen CA393774294, ClinVar RCV003628031, CADD 30.00, Pathogenic
- Q49E (p.Gln49Glu), rs200132079, ClinGen CA7725187, ClinVar RCV001523583, ExAC rs200132079, REVEL 0.34, CADD 0.16, Benign, Progressive sclerosing poliodystrophy
- Q49P (p.Gln49Pro), TOPMed rs1327144196
- Q49R (p.Gln49Arg), TOPMed rs1327144196, REVEL 0.29, CADD 3.90, Uncertain significance, Progressive sclerosing poliodystrophy
- Q50* (p.Gln50Ter), cosmic curated COSV99174, CADD 29.60
- Q50K (p.Gln50Lys), rs752556685, ClinGen CA7725185, ClinVar RCV001313758, ExAC rs752556685, REVEL 0.31, CADD 0.33, Uncertain significance, Progressive sclerosing poliodystrophy
- Q50R (p.Gln50Arg), gnomAD rs1301789510, REVEL 0.30, CADD 0.13
- Q51E (p.Gln51Glu), rs2509277064, ClinGen CA393774243, ClinVar RCV003628433, ClinVar RCV004371791, Uncertain significance, Inborn genetic diseases; Progressive sclerosing poliodystrophy
- Q51L (p.Gln51Leu), gnomAD rs1478709276, REVEL 0.31, CADD 7.14, Uncertain significance
- Q51R (p.Gln51Arg), rs1478709276, ClinGen CA393774237, ClinVar RCV001372467, gnomAD rs1478709276, Uncertain significance, Progressive sclerosing poliodystrophy
- Q51H (p.Gln51His), Ensembl rs1453538834, Benign
- Q52E (p.Gln52Glu), ESP rs376683989, ExAC rs376683989, TOPMed rs376683989, gnomAD rs376683989, Uncertain significance
- Q52H (p.Gln52His), rs587781117, ClinGen CA7725182, ClinVar RCV001589368, ClinVar RCV001866118, REVEL 0.27, CADD 5.84, Uncertain significance, Inborn genetic diseases; not provided; Progressive sclerosing poliodystrophy
- Q52K (p.Gln52Lys), rs376683989, ClinGen CA316623, ClinVar RCV000758285, ClinVar RCV000992680, REVEL 0.28, CADD 0.41, Conflicting interpretations, POLG-related disorder; Inborn genetic diseases; not provided
- Q53* (p.Gln53Ter), rs2509277006, ClinGen CA393774175, ClinVar RCV003627563, CADD 29.00, Pathogenic
- Q53H (p.Gln53His), rs587781118, ClinGen CA10602197, ClinVar RCV000758287, ClinVar RCV004027157, REVEL 0.40, CADD 6.96, Uncertain significance, Inborn genetic diseases; Progressive sclerosing poliodystrophy
- Q53P (p.Gln53Pro), rs1064795981, ClinGen CA10602308, ClinVar RCV000991338, ClinVar RCV002402414, REVEL 0.35, CADD 6.67, Uncertain significance, Progressive sclerosing poliodystrophy
- Q54* (p.Gln54Ter), rs774768199, ClinGen CA7725179, ClinVar RCV000735156, ClinVar RCV003461011, CADD 35.00, Pathogenic
- Q54A (p.Gln54Ala), rs2509276845, ClinVar RCV003515812, Likely benign
- Q54P (p.Gln54Pro), ExAC rs768875981, gnomAD rs768875981, REVEL 0.23, CADD 7.29
- Q55* (p.Gln55Ter), rs2055626123, ClinGen CA393774032, ClinVar RCV001582267, ClinVar RCV003626676, CADD 34.00, Pathogenic
- Q55P (p.Gln55Pro), TOPMed rs1223764065, gnomAD rs1223764065, REVEL 0.19, CADD 12.30
- P56H (p.Pro56His), cosmic curated COSV51522, Ensembl rs1022612492, REVEL 0.14, CADD 15.00, Uncertain significance
- P56L (p.Pro56Leu), rs1022612492, ClinGen CA274566405, ClinVar RCV002658015, ClinVar RCV004719267, REVEL 0.13, CADD 9.98, Uncertain significance, Progressive sclerosing poliodystrophy; not provided
- P56Q (p.Pro56Gln), cosmic curated COSV51519
- P56R (p.Pro56Arg), rs1022612492, ClinGen CA393773955, ClinVar RCV000530802, Ensembl rs1022612492, REVEL 0.11, CADD 9.46, Uncertain significance, Progressive sclerosing poliodystrophy
- P56S (p.Pro56Ser), Ensembl rs2055625771, REVEL 0.18, CADD 7.78
- Q57R (p.Gln57Arg), TOPMed rs916297909, REVEL 0.17, CADD 12.60
- Q58* (p.Gln58Ter), rs2055625602, ClinGen CA393773931, ClinVar RCV001233059, Ensembl rs2055625602, CADD 35.00, Pathogenic
- Q58H (p.Gln58His), gnomAD rs1285538669, REVEL 0.18, CADD 14.00
- P59L (p.Pro59Leu), rs1057518590, ClinGen CA16042908, cosmic curated COSV51521, ClinVar RCV000414353, Uncertain significance, not specified; Progressive sclerosing poliodystrophy
- Q60* (p.Gln60Ter), rs780379693, ClinGen CA393773862, ClinVar RCV002715795, ClinVar RCV003482419, CADD 36.00, Pathogenic
- Q60K (p.Gln60Lys), rs780379693, ClinGen CA7725167, ClinVar RCV001235892, ExAC rs780379693, REVEL 0.13, CADD 17.20, Uncertain significance, Progressive sclerosing poliodystrophy
- Q60P (p.Gln60Pro), rs2509276648, ClinGen CA393773858, ClinVar RCV003032953, Uncertain significance, Progressive sclerosing poliodystrophy
- S63C (p.Ser63Cys), rs960812250, ClinGen CA393773780, ClinVar RCV002253009, ClinVar RCV005095854, Uncertain significance, See cases; Progressive sclerosing poliodystrophy
- S63F (p.Ser63Phe), rs960812250, ClinGen CA274566350, ClinVar RCV002008375, TOPMed rs960812250, REVEL 0.20, CADD 23.90, Uncertain significance, Progressive sclerosing poliodystrophy
- S63P (p.Ser63Pro), rs781006710, ClinGen CA7725164, ClinVar RCV001362584, ClinVar RCV001509501, REVEL 0.24, CADD 19.40, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- S63Y (p.Ser63Tyr), TOPMed rs960812250, gnomAD rs960812250, Uncertain significance
- S64L (p.Ser64Leu), rs1397887879, ClinGen CA393773758, ClinVar RCV003100461, TOPMed rs1397887879, REVEL 0.17, CADD 23.20, Uncertain significance, Progressive sclerosing poliodystrophy
- S64W (p.Ser64Trp), rs1397887879, ClinGen CA10602210, ClinVar RCV000758444, ClinVar RCV005010756, REVEL 0.45, CADD 29.20, Uncertain significance, not provided; Progressive external ophthalmoplegia with mitochondrial DNA deleti
- E65K (p.Glu65Lys), TOPMed rs2055625060, Uncertain significance, Progressive sclerosing poliodystrophy
- G67A (p.Gly67Ala), rs1399456619, ClinGen CA393773680, ClinVar RCV001370598, ClinVar RCV002488166, REVEL 0.21, CADD 14.90, Uncertain significance, Progressive sclerosing poliodystrophy; Mitochondrial DNA depletion syndrome 1; P
- G67R (p.Gly67Arg), rs1415744247, ClinGen CA393773685, ClinVar RCV001322797, TOPMed rs1415744247, REVEL 0.14, CADD 19.50, Uncertain significance, Progressive sclerosing poliodystrophy
- G67W (p.Gly67Trp), TOPMed rs1415744247, gnomAD rs1415744247, Uncertain significance
- Q68* (p.Gln68Ter), rs202039305, ClinGen CA10602212, ClinVar RCV000296330, ClinVar RCV000758262, CADD 37.00, Pathogenic
- Q68H (p.Gln68His), rs2509276536, ClinGen CA393773647, ClinVar RCV003627806, REVEL 0.34, CADD 24.70, Uncertain significance, Progressive sclerosing poliodystrophy
- Q68L (p.Gln68Leu), rs1171419088, ClinGen CA393773649, ClinVar RCV001863391, TOPMed rs1171419088, Uncertain significance, Progressive sclerosing poliodystrophy
- Q68P (p.Gln68Pro), TOPMed rs1171419088, gnomAD rs1171419088, REVEL 0.33, CADD 25.00, Uncertain significance
- Q68R (p.Gln68Arg), TOPMed rs1171419088, gnomAD rs1171419088, REVEL 0.32, CADD 23.30, Uncertain significance
- L69P (p.Leu69Pro), Ensembl rs2141815548
- R70Q (p.Arg70Gln), rs1031558097, ClinGen CA274566338, ClinVar RCV001934834, Ensembl rs1031558097, REVEL 0.76, CADD 26.90, Uncertain significance, Progressive sclerosing poliodystrophy
- R70W (p.Arg70Trp), cosmic curated COSV51520, Uncertain significance, Progressive sclerosing poliodystrophy
- H71R (p.His71Arg), rs2509276490, ClinGen CA393773574, ClinVar RCV003515939, REVEL 0.23, CADD 17.30, Uncertain significance, Progressive sclerosing poliodystrophy
- H71Y (p.His71Tyr), rs1596362518, ClinGen CA393773586, ClinVar RCV003019492, Ensembl rs1596362518, Uncertain significance, Progressive sclerosing poliodystrophy
- N72S (p.Asn72Ser), rs796052897, ClinGen CA316778, ClinVar RCV000730674, ClinVar RCV003626609, REVEL 0.81, CADD 24.90, Uncertain significance, not provided; Progressive sclerosing poliodystrophy
- N72Y (p.Asn72Tyr), ExAC rs777759802, gnomAD rs777759802, REVEL 0.96, CADD 27.70
- P73A (p.Pro73Ala), gnomAD rs1196343583, REVEL 0.31, CADD 16.70
- P73L (p.Pro73Leu), rs199760610, ClinGen CA274566286, ClinVar RCV003627612, TOPMed rs199760610, REVEL 0.65, CADD 23.30, Uncertain significance, Progressive sclerosing poliodystrophy
- P73R (p.Pro73Arg), TOPMed rs199760610, gnomAD rs199760610, REVEL 0.73, CADD 26.60, Uncertain significance
- P73T (p.Pro73Thr), gnomAD rs1196343583
- L74F (p.Leu74Phe), cosmic curated COSV51521
- D75Y (p.Asp75Tyr), cosmic curated COSV10635
- I76M (p.Ile76Met), ExAC rs765015505
- I76V (p.Ile76Val), TOPMed rs1261825887, REVEL 0.64, CADD 24.00
- Q77* (p.Gln77Ter), rs2509276392, ClinGen CA393773418, ClinVar RCV002824674, CADD 39.00, Pathogenic
- Q77H (p.Gln77His), rs750555988, ClinGen CA7725156, ClinVar RCV002814667, ExAC rs750555988, REVEL 0.93, CADD 26.10, Uncertain significance, Progressive sclerosing poliodystrophy
- Q77R (p.Gln77Arg), Ensembl rs2055624394
- M78V (p.Met78Val), ExAC rs767576217, gnomAD rs767576217, REVEL 0.92, CADD 25.80
- L79F (p.Leu79Phe), rs2509276366, ClinGen CA393773371, ClinVar RCV003317827, Uncertain significance, not specified
- L79P (p.Leu79Pro), Ensembl rs2055624249
Public POLG analysis runs
- POLG analysis run — POLG (2,426 variants) — completed 2026-08-19